share_log

HC Wainwright & Co. Upgrades AcelRx Pharmaceuticals to Buy, Announces $8 Price Target

HC Wainwright & Co. Upgrades AcelRx Pharmaceuticals to Buy, Announces $8 Price Target

HC Wainwright & Co.将AcelRx Pharmicals升级为收购,宣布目标股价为8美元
Benzinga ·  2023/08/18 06:21

HC Wainwright & Co. analyst Ed Arce upgrades AcelRx Pharmaceuticals (NASDAQ:ACRX) from Neutral to Buy and announces $8 price target.

HC Wainwright & Co. 分析师埃德·阿斯将AcelRX Pharmicals(纳斯达克股票代码:ACRX)从中性上调至买入,并宣布目标股价为8美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发